| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 20,925,652 |
100% | ₹1,550.59 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Total | 20,925,652 | ₹1,550.59 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 40 | ₹29,640 |
| Retail (Max — 13 Lots) | 13 | 260 | ₹192,660 |
| S-HNI (Min — 14 Lots) | 14 | 280 | ₹207,480 |
| B-HNI (Min — 68 Lots) | 68 | 1,360 | ₹1,007,760 |
| Particulars | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 630.75 | 736.35 | 888.48 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 234.89 | 174.93 | 240.08 |
| Net Worth | 999.37 | 1103.22 | 1290.00 |
| Total Assets | 1182.55 | 1312.80 | 1513.98 |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | 86.35 | 60.59 | 31.24 |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Concord Biotech Ltd. IPO is subscribed 1.00 times by Aug 08, 2023. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Concord Biotech Ltd. IPO retail category is subscribed 1.00 times as of 08 Aug 2023. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 04 Aug 2023 and closes 08 Aug 2023. Min investment: ₹14,820 (1 lot = 20 shares). UPI mandate: 2023-08-08.
The Concord Biotech Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (MUFG Intime India Pvt.Ltd.) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 11 Aug 2023. Refunds: on 14 Aug 2023.
The Concord Biotech Ltd. IPO listing date is 18 Aug 2023, Friday. Listed on: NSE & BSE. Issue price: ₹741. Estimated listing: ₹741. GMP: NIL.
The Concord Biotech Ltd. IPO closes on 08 Aug 2023, Tuesday. UPI mandate: 2023-08-08. Allotment: 11 Aug 2023. Listing: 18 Aug 2023.